Acting for VISEN Pharmaceuticals in its HK$783m (approx. US$100m) initial public offering

Cayman Islands counsel to VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, in its initial public offering on the Hong Kong Stock Exchange in March 2025. Lucy Anderson led our team.